Michael Ackermann

Chairman, Oyster Point Pharmaceuticals, Inc.; Chairman, Tarsus Pharmaceuticals, Inc.; CEO, Presidio Medical, Inc.

John Berdahl, MD

CEO, Equinox; Ophthalmologist, Vance Thompson Vision

Ryan Bouchard

VP Medical Devices, Ora, Inc.

Janet Burk

Publisher, Retina Today

Tom Burns

President and CEO, Glaukos

Chris Calcaterra

COO, Glaukos

Steve Charles, MD

Founder, Charles Retina Institute

Andy Corley

Partner, Flying-L Partners

Vincent Deramo, MD

Co-founder, ConnectOnCall; Partner, Long Island Vitreoretinal Consultants

Bernie Haffey

Founder, Haffey & Co.

Paul Hallen

Global Head Retina & Glaucoma, Alcon

Rick Heinick

Chairman, TearClear

John Hendrick

President, SafeCo, LLC

Malik Kahook, MD

Vice-Chair Translational Research and Chief, Glaucoma Service, University of Colorado Eye Center

Ron Kurtz, MD

CEO, RxSight, Inc.

Mike Lambert, MD

Founder, Retina and Vitreous of Texas; Board Member, LVX System

James Mazzo

Global President, Ophthalmic Devices, Carl Zeiss Meditec

Zeshan Muhammedi

Co-founder, CEO, FundRx

Quinton Oswald

CEO, Notal Vision

Ram Palanki

Senior VP of Commercial Strategy and Operations, REGENXBIO

Samir Patel, MD

Ed Peterson

Global General Manager, Aviana Molecular Technologies

Jane Rady

Global General Manager, Aviana Molecular Technologies

Firas Rahhal, MD

Partner, ExSight Ventures, Sr. Partner, Retina-Vitreous Associates Medical Group

Tushar Ranchod, MD

Founder, Chairman, CTO, BroadSpot Imaging Corp.; Partner, Bay Area Retina

David Robinson

Partner, Protean, LLC

Aron Shapiro

Sr. VP and Chief Commercial Officer, Ora, Inc.

Ramin Valian

VP Retina, Surgical & Upstream Marketing, Allergan

Jeffry Weinhuff

Managing Partner, Visionary Venture Fund

Bob Zatarain

CEO, Oculus Surgical, Inc.